- Reappraising the 2016 WHO classification for diffuse glioma. Neuro-Oncology. 2017 In Process GET IT
- Molecular and histologic characteristics of pseudoprogression in diffuse gliomas. Journal of Neuro-Oncology. 2016 In Process GET IT
Is there a role for early chemotherapy in the management of pituitary adenomas?.
Times cited: 2
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas.
Times cited: 5
- Standardized patient outcomes trial (SPOT) in neurology. Medical education online. 2011 Academic Article GET IT